ELCO Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-30,792
| Closed | -$190K | – | 166 |
|
|
2024
Q2 | $190K | Sell |
30,792
-5,229
| -15% | -$32.3K | 0.11% | 145 |
|
|
2024
Q1 | $183K | Buy |
36,021
+5,368
| +18% | +$27.3K | 0.11% | 142 |
|
|
2023
Q4 | $184K | Sell |
30,653
-1,158
| -4% | -$6.94K | 0.12% | 132 |
|
|
2023
Q3 | $225K | Buy |
31,811
+18,269
| +135% | +$129K | 0.16% | 112 |
|
|
2023
Q2 | $95.3K | Buy |
+13,542
| New | +$95.3K | 0.07% | 123 |
|